Key result
This review highlights the epidemiology, screening, management, and impact of social determinants of health on diabetic autonomic neuropathies, including cardiovascular and gastrointestinal forms.
Why the study?
While cardiovascular autonomic neuropathy is extensively studied, emerging data highlight the impact of other forms of diabetic autonomic neuropathy on healthcare and patient-reported outcomes.
This review highlights the epidemiology, diagnosis, and management of diabetic autonomic neuropathies, including cardiovascular autonomic neuropathy.
Answers are grounded in this paper and cite their sources.
Supports attention to social determinants in diabetic autonomic neuropathy management; leaves open need for interventional studies.
This article summarizes the latest epidemiology of diabetic autonomic neuropathy (DAN), and provides a brief overview on epidemiology, current outcomes measures for screening and diagnosis in research and clinical settings, the latest evidence on effective management, and novel perspectives on the impacts of social determinants of health in development and management of DAN. Among the various forms of diabetic neuropathy, distal symmetric polyneuropathy and diabetic autonomic neuropathies, particularly cardiovascular autonomic neuropathy, are by far the most studied. However, emerging data highlight the impact of other forms of autonomic neuropathies such as gastrointestinal and urogenital autonomic neuropathies, on healthcare and patients' reported outcomes [1].
No takes yet. Share an insight, caveat, or question.
Rodica Pop‐Busui (2023) conducted a review in Diabetic autonomic neuropathy. This review highlights the epidemiology, screening, management, and impact of social determinants of health on diabetic autonomic neuropathies, including cardiovascular and gastrointestinal forms.
Synapse has enriched 10 related papers. Consider them for comparative context: